SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet's $GOOGL is trending as discussions revolve around its AI capabilities, particularly with the Gemini 3 model potentially surpassing OpenAI. The stock is also seeing increased investor confidence and speculation about a potential $4 trillion market cap. Community members are actively debating its position in the AI race, comparing it to Nvidia and discussing potential revenue streams from its TPUs.

Alphabet Inc - Ordinary Shares - Class C

Alphabet's stock is trending as rumors circulate about Meta and other hyperscalers potentially turning to Google's TPUs, sparking optimism about new revenue streams. The community is buzzing about Google's AI advancements, particularly Gemini, and the potential for Google to gain market share in the AI chip space. Some investors are drawing comparisons to Nvidia, while others highlight Alphabet's broader AI ecosystem and strong financial position.

Turkey Time

Turkey Crypto ($TURKEY) is trending within the Solana ecosystem, with community members anticipating a potential surge related to the Thanksgiving holiday. Discussions center on its chart patterns and overall readiness for a breakout. The token is also being promoted as a timely purchase opportunity.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending as investors evaluate its potential for growth beyond the pandemic era, particularly its expansion into AI and enterprise solutions. The community is actively discussing the company's balance sheet, profitability, and recent analyst ratings, with some highlighting its cash reserves and buyback program. Despite mixed opinions on its growth prospects, Zoom's strategic moves and financial stability remain key talking points.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending following an upbeat long-term revenue forecast and discussion of AI growth plans. The community is analyzing analyst ratings and debating whether the company can achieve its ambitious targets. Some are citing the stock's attractive valuation relative to peers, while others express concerns about execution and the CEO's recent actions.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending heavily as the community rallies around the project, with many users expressing excitement and anticipation for its future. Discussions revolve around the concept of earning crypto by walking and the potential for long-term gains. The community highlights the token's utility within the Sweat Wallet app, where users can stake coins and participate in raffles.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI (PONY) is trending due to an expanded partnership with Sunlight Mobility to scale robotaxi deployment, causing optimism around its growth potential. The community is discussing the implications of this asset-light model and potential revenue impacts, as well as anticipation for upcoming earnings. Bullish sentiment is building, with some viewing PONY as undervalued and poised for a significant uptrend in the autonomous driving sector.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is trending due to positive sentiment following their Q4 earnings report and subsequent FY26 guidance, with community members highlighting the increased backlog and revenue expectations. Discussions revolve around the company's position in the growing BESS (Battery Energy Storage System) market and potential for significant growth, especially with AI driving demand for more power. Some are speculating on a potential short squeeze and potential takeover by BlackRock.

Layer3

Layer3 ($L3) is trending amid discussions about potential catalysts and future growth, with community members eyeing possible price movements and new all-time highs. Some traders are pointing to its interoperability and low market cap as reasons for optimism, while others are wary of potential pump-and-dump schemes. Recent news highlights Bybit and Mantle launching a campaign distributing rewards through quests hosted by Layer3.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

OSCR is trending due to uncertainty around the Affordable Care Act (ACA) subsidies, following Trump's proposal to extend them and subsequent White House delay due to Republican backlash. The community is actively debating the potential impact of these policy shifts on Oscar Health's business model and future profitability, as well as the possibility of a short squeeze. Some traders suggest the stock is undervalued and presents a buying opportunity, while others express concern about the company's long-term prospects amid policy volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Moderate Buy" from Analysts

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are covering the firm, MarketBeat...

Insider Selling: 4D Molecular Therapeutics (NASDAQ:FDMT) Insider Sells $17,314.65 in Stock

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Get Free Report) insider Scott Bizily sold 1,635 shares of the company's stock in a transaction on Monday, November 17th. The shares were sold at an...

4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Up 6.2% - What's Next?

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Up 6.2% - Time to Buy...

4DMT Appoints Kristian Humer As CFO

(RTTNews) - 4D Molecular Therapeutics, Inc. (FDMT), a biotechnology company, Monday announced that it has appointed Kristian Humer as its new chief financial officer...

4D Molecular Therapeutics (NASDAQ:FDMT) Upgraded at Wall Street Zen

Wall Street Zen upgraded 4D Molecular Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

HC Wainwright Has Optimistic Outlook of FDMT FY2026 Earnings

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) - Equities researchers at HC Wainwright raised their FY2026 earnings estimates for shares of 4D Molecular Therapeutics in a report issued...

FY2025 Earnings Forecast for FDMT Issued By Chardan Capital

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) - Research analysts at Chardan Capital lifted their FY2025 earnings per share estimates for 4D Molecular Therapeutics in a research note...

Brokers Offer Predictions for FDMT Q1 Earnings

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of 4D Molecular Therapeutics in...

Cantor Fitzgerald Issues Negative Forecast for FDMT Earnings

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) - Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for shares of 4D Molecular Therapeutics...

Leerink Partnrs Issues Pessimistic Outlook for FDMT Earnings

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT - Free Report) - Leerink Partnrs decreased their FY2025 earnings estimates for shares of 4D Molecular Therapeutics in a report issued on Monday, November...

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

4D Molecular Therapeutics Inc

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

Current Price	$10.89
Prev Close	$10.84
Open	$10.86
Dividend Yield	0.00%
50-Day Moving Average	$9.77
Beta	1.28
Avg. Volume	873,657.91
PE Ratio	-2.77

52-Week High	$12.34
52-Week Low	$2.24
Market Capitalization	$619.34M
EPS (Annual)	-$2.98
Price to Book	1.38
Revenue Per Employee	$163.00
Enterprise Value/EBITDA	N/A

FDMT
4D Molecular Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FDMT News

FDMT4D Molecular Therapeutics Inc